DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Davies C, Pan H, Godwin J et al.
and ATLAS Collaborators Worldwide. ATLAS - 10 vs. 5 years of adjuvant tamoxifen (TAM) in ER+ disease: Effects on outcome in the first and in the second decade after diagnosis.
Cancer Res 2012;
72 (Suppl.) S1-S2
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.